Abstract
The patient was a 66-year-old man who had advanced gastric cancer with metastasis to liver and lymph nodes. He received daily oral administration of 100 mg of TS-1 for 28 days followed by 14 days rest as one treatment course. After 2 coures, regression of the primary lesion and reduction in size of the liver and lymph metastases were observed.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / secondary
-
Administration, Oral
-
Antimetabolites, Antineoplastic / administration & dosage*
-
Drug Administration Schedule
-
Drug Combinations
-
Humans
-
Liver Neoplasms / secondary
-
Lymph Nodes / pathology
-
Lymphatic Metastasis
-
Male
-
Middle Aged
-
Neoplasm Staging
-
Oxonic Acid / administration & dosage*
-
Pyridines / administration & dosage*
-
Stomach Neoplasms / drug therapy*
-
Stomach Neoplasms / pathology
-
Survivors
-
Tegafur / administration & dosage*
Substances
-
Antimetabolites, Antineoplastic
-
Drug Combinations
-
Pyridines
-
S 1 (combination)
-
Tegafur
-
Oxonic Acid